Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve The Audited Financial Results ....
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Pharmalabs Ltd has informed exchanges that a Board meeting is scheduled for May 18, 2026. The meeting will consider and approve the Audited Financial Results for Q4 and the financial year ended March 31, 2026, subject to review by the Audit Committee. The Board will also consider recommending a Final Dividend for FY 2025-26. The insider trading window remains closed until May 20, 2026. This is a standard regulatory intimation under SEBI Listing Regulations.
This is a routine pre-result announcement notice. No financial data or signals are provided at this stage. Actual results and any dividend declaration will be disclosed after the meeting on May 18, 2026.